Adlai Nortye Group Ltd. SEC filings ANL
Adlai Nortye Group Ltd. has 114 filings in SEC EDGAR's recent list, going back to Dec 21, 2022. Its latest annual report, Form 20-F, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 15, 2026 | — |
| EFFECT | Filing | Apr 28, 2026 | — |
| CORRESP | Letter to the SEC | Apr 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 2, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2024 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| CERT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| 8-A12B | Filing | Aug 18, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2023 | — |
| CORRESP | Letter to the SEC | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| 8-A12B | Filing | Aug 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2023 | — |
| DRSLTR | Filing | Jun 22, 2023 | — |
| DRS/A | Filing | Jun 22, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| DRSLTR | Filing | May 11, 2023 | — |
| DRS/A | Filing | May 11, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| DRSLTR | Filing | Apr 14, 2023 | — |
| DRS/A | Filing | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2023 | — |
| DRSLTR | Filing | Feb 27, 2023 | — |
| DRS/A | Filing | Feb 27, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2023 | — |
| DRSLTR | Filing | Dec 21, 2022 | — |
| DRS | Filing | Dec 21, 2022 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Singapore
- Headquarters
- Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944552
- Former names
- Adlai Nortye Ltd. (until Aug 19, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.